You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Advanced robotics enable successful lung biopsies
Together we completed over 20,000 cases.1 When using MONARCH™, physicians achieved over 15% improvement in overall diagnostic yield2 compared to traditional bronchoscopy. This means fewer patients had to ‘wait and see.’
1.7
average number of biopsies a patient needs to get diagnosis3
33.5%
5-year survival rate if lung cancer has spread to regional lymph nodes4
61.2%
survival rate if lung cancer is diagnosed and treated early5
Clinical Studies
Robotic-assisted Bronchoscopy and Cone-beam CT (CBCT). A Retrospective Series.
Learn from a physician’s recent experience in the use of CBCT with the MONARCH™ Platform, where 100% tool-in-lesion confirmation was achieved.6
AABIP 2022 Poster: Demographic and Lesion Characteristics of first 443 subjects in TARGET.
Learn about the interim analysis of a large multicenter prospective real-world observation study. RAB with MONARCH™ Platform had 97.5% navigation success with median lesion size reported as 18.5 mm. Compared to a prior prospective study of the MONARCH™ Platform, nodule size appears smaller and procedure time is shorter in this cohort.7
Gateway Customer Portal
Our customers have access to data and insights through our secure web-portal to support their MONARCH™ experience. Improve efficiency with access to platform usage data, order information, training, and marketing support materials.

Vision in the periphery
The MONARCH™ Platform is designed to provide vision throughout the procedure. Limited vision, or no vision, forces you to rely on other technology to approximate location and trajectory of your tools, which can make biopsies more challenging.
With an integrated camera, you now have the added benefit of being able to directly visualize the biopsy field and instruments.
The MONARCH™ Platform is also compatible with the leading advanced intraoperative imaging systems, inclusive of fixed gantry or mobile interventional CBCT and mobile CT imaging systems.